SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement • March 4th, 2016 • Avalanche Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This Separation Agreement and General Release ("Agreement") is made by and between Hans P. Hull ("Executive") and Avalanche Biotechnologies, Inc. (the "Company") (collectively referred to as the "Parties" or individually referred to as a “Party”), effective as of the eighth day following Executive’s signature of this Agreement without revocation (the “Effective Date”).
Consulting AgreementConsulting Agreement • March 4th, 2016 • Avalanche Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This Consulting Agreement (the “Agreement”) is made and entered into as of February 12, 2016 (the “Effective Date”), by and between Avalanche Biotechnologies, Inc., a Delaware, USA corporation with an address at 1035 O’Brien Drive, Menlo Park, CA 94025 (the “Company”), and Hans Hull, an individual with an address at *** (the “Consultant”). The Company and the Consultant may be referred to herein individually as “Party” or collectively, as “Parties.”
